T Man Pharmaceutical PCL (TMAN)

Thailand
Currency in THB
10.90
+0.20(+1.87%)
Delayed Data·
TMAN Scorecard
Full Analysis
Valuation implies a strong free cash flow yield
TMAN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10.7011.10
52 wk Range
9.9019.30
Key Statistics
Edit
Bid/Ask
10.80 / 10.90
Prev. Close
10.7
Open
10.7
Day's Range
10.7-11.1
52 wk Range
9.9-19.3
Volume
77.1K
Average Volume (3m)
478.27K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TMAN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
17.90
Upside
+64.22%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low earnings multiple
No news in this category
Looks like there are no results in this news category

T Man Pharmaceutical PCL Company Profile

T.Man Pharmaceutical Public Company Limited manufactures and sells pharmaceuticals and health care products in Thailand. The company operates through three segments: Manufactured Products Under Own Brand, Manufactured Products Under Third Parties’ Brand, and Trading Products. It offers antibacterial, central nervous system, corticosteroid, chronic diseases, gastrointestinal, respiratory, and musculoskeletal drugs, as well as medical devices, vaginal suppositories, dermatological, mouth, and throat products. The company also provides herbal and traditional medicines, dietary supplements, vitamins and minerals, skin care and aesthetics, whey protein, and mommy and kid products, as well as cosmetics, modern medicines, and vita-c products. In addition, it offers products under various brand names, such as Iyara, Propoliz, POLAR, and Fibermate. Further, the company offers original equipment manufacturing services. Additionally, it offers medicines in the form of tablets, capsules, powders, liquids, and semisolids. The company also exports its products. T.Man Pharmaceutical Public Company Limited was founded in 1991 and is based in Bangkok, Thailand.

Employees
944
Market
Thailand

Compare TMAN to Peers and Sector

Metrics to compare
TMAN
Peers
Sector
Relationship
P/E Ratio
9.8x12.4x−0.5x
PEG Ratio
−0.48−0.190.00
Price/Book
2.2x1.8x2.6x
Price / LTM Sales
1.9x1.7x2.9x
Upside (Analyst Target)
67.3%23.9%45.8%
Fair Value Upside
Unlock13.1%8.6%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 17.90
(+64.22% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.20%
Dividend Yield
3.55%
Industry Median 3.73%
Annualised payout
0.38
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Feb 25, 2025
EPS / Forecast
0.28 / --
Revenue / Forecast
580.09M / --
EPS Revisions
Last 90 days

FAQ

What Is the T Man Pharmaceutical PCL (TMAN) Stock Price Today?

The T Man Pharmaceutical PCL stock price today is 10.90

What Stock Exchange Does T Man Pharmaceutical PCL Trade On?

T Man Pharmaceutical PCL is listed and trades on the Thailand Stock Exchange stock exchange.

What Is the Stock Symbol for T Man Pharmaceutical PCL?

The stock symbol for T Man Pharmaceutical PCL is "TMAN."

Does T Man Pharmaceutical PCL Pay Dividends? What’s The Current Dividend Yield?

The T Man Pharmaceutical PCL dividend yield is 3.55%.

What Is the T Man Pharmaceutical PCL Market Cap?

As of today, T Man Pharmaceutical PCL market cap is 4.28B.

What Is T Man Pharmaceutical PCL's Earnings Per Share (TTM)?

The T Man Pharmaceutical PCL EPS (TTM) is 1.20.

From a Technical Analysis Perspective, Is TMAN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.